Verapamil Hydrochloride

DRUG3 trials

Sponsors

City of Hope Medical Center, Cambridge University Hospitals NHS Foundation Trust, Muhammad Aamir Latif

Conditions

Cardiovascular System DiseaseDrug-Related Side Effects and Adverse ReactionsKeloidRecurrent Hodgkin LymphomaRefractory Hodgkin Lymphoma

Phase 1

Brentuximab Vedotin, Cyclosporine, and Verapamil Hydrochloride in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma

CompletedNCT03013933

City of Hope Medical CenterRecurrent Hodgkin Lymphoma, Refractory Hodgkin Lymphoma

Start: 2017-05-03End: 2022-05-24Updated: 2024-02-22

A Study of the Pharmacokinetic and Pharmacodynamic Responses in Healthy and Altered Human Cardiovascular Systems

TerminatedNCT03098680

Cambridge University Hospitals NHS Foundation TrustCardiovascular System Disease, Drug-Related Side Effects and Adverse Reactions

Start: 2017-04-24End: 2020-02-29Updated: 2021-03-22

Unknown Phase

Comparison of Intralesional Triamcinolone Acetonide Treatment With Intralesional Verapamil Hydrochloride in Keloids

CompletedNCT07420166

Muhammad Aamir LatifKeloid

Start: 2025-01-01End: 2025-06-30Updated: 2026-02-19